Zacks Investment Management Invests $1.98 Million in Doximity, Inc. (NASDAQ:DOCS)

Zacks Investment Management acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 37,163 shares of the company's stock, valued at approximately $1,984,000.

Several other large investors also recently modified their holdings of the stock. QSV Equity Investors LLC boosted its position in Doximity by 0.3% in the fourth quarter. QSV Equity Investors LLC now owns 60,763 shares of the company's stock valued at $3,244,000 after buying an additional 186 shares in the last quarter. Handelsbanken Fonder AB raised its stake in shares of Doximity by 0.7% in the fourth quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock valued at $1,586,000 after acquiring an additional 200 shares during the last quarter. UMB Bank n.a. boosted its holdings in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after acquiring an additional 235 shares in the last quarter. Fielder Capital Group LLC grew its position in Doximity by 4.5% during the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock worth $293,000 after acquiring an additional 235 shares during the last quarter. Finally, Larson Financial Group LLC increased its holdings in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Doximity Trading Up 2.1 %

Shares of DOCS stock traded up $1.08 on Tuesday, hitting $52.36. 1,505,867 shares of the stock were exchanged, compared to its average volume of 1,982,271. The business has a 50-day moving average of $62.49 and a 200 day moving average of $55.97. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The firm has a market capitalization of $9.78 billion, a P/E ratio of 52.36, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on DOCS shares. Truist Financial lowered their target price on Doximity from $65.00 to $58.00 and set a "hold" rating for the company in a research note on Thursday, April 10th. Canaccord Genuity Group lifted their price objective on Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a research report on Friday, February 7th. Piper Sandler upgraded shares of Doximity from a "neutral" rating to an "overweight" rating and upped their target price for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Bank of America lifted their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Finally, Raymond James restated an "outperform" rating and issued a $83.00 price objective (up from $65.00) on shares of Doximity in a report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $65.00.

Insider Activity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 37.40% of the stock is owned by corporate insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.